# Amplitude Therapeutics, Inc.

Canonical: https://abierto.us/vendors/amplitude-therapeutics-inc-lkkrwnj3wqn7

- UEI: LKKRWNJ3WQN7
- CAGE: 9VMN7
- Location: Boston, MA
- Awards in window: 1 (1 transactions), $732,813 obligated, August 20, 2024 to August 20, 2024

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 1 awards, $732,813

## Industries

- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $732,813

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75A50124C00036 (definitive contract): $732,813, Barda - Aspr / Daappo / Barda DCMA. Amplitude Therapeutics-A Split-Formulated Trans-Amplifying Rna Encoded Anti-Neuraminidase Monoclonal Antibody. https://www.usaspending.gov/award/CONT_AWD_75A50124C00036_7505_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/amplitude-therapeutics-inc-lkkrwnj3wqn7.